| 29 | MERS-CoV |
| 23 | Coronavirus |
| 16 | coronavirus |
| 12 | MERS |
| 11 | COVID-19 |
| 10 | Saudi Arabia |
| 10 | SARS-CoV |
| 9 | epidemiology |
| 8 | Middle East respiratory syndrome |
| 8 | Epidemiology |
| 7 | virus |
| 7 | influenza |
| 7 | Virus |
| 7 | HIV |
| 6 | pneumonia |
| 6 | antiviral |
| 6 | Transmission |
| 5 | innate immunity |
| 5 | SARS |
| 5 | SARS-CoV-2 |
| 5 | Middle East respiratory syndrome coronavirus |
| 5 | Bovine respiratory disease |
| 4 | viruses |
| 4 | respiratory virus |
| 4 | respiratory syncytial virus |
| 4 | immunity |
| 4 | human coronavirus |
| 4 | cytostatic |
| 4 | coronaviruses |
| 4 | cancer |
| 4 | antibody |
| 4 | Children |
| 3 | vaccines |
| 3 | vaccine development |
| 3 | vaccination |
| 3 | real-time PCR |
| 3 | polymerase chain reaction |
| 3 | outbreak |
| 3 | infection |
| 3 | immune response |
| 3 | envelope protein |
| 3 | encephalitis |
| 3 | autophagy |
| 3 | autoimmunity |
| 3 | asthma |
| 3 | antibiotics |
| 3 | Respiratory |
| 3 | Reference gene |
| 3 | RT-qPCR |
| 3 | Qatar |
| 3 | Prevalence |
| 3 | Pneumonia |
| 3 | Outbreaks |
| 3 | Multiple sclerosis |
| 3 | Middle East Respiratory Syndrome |
| 3 | Isolation |
| 3 | Influenza |
| 3 | Infectious bronchitis virus |
| 3 | Immune response |
| 3 | Hepatitis C virus |
| 3 | Hajj |
| 3 | Epitope |
| 3 | ELISA |
| 3 | Diseases |
| 3 | Diarrhoea |
| 3 | Diarrhea |
| 3 | Corona virus |
| 3 | China |
| 3 | Chicken |
| 3 | Cattle |
| 3 | Bovine respiratory syncytial virus |
| 3 | Biosecurity |
| 3 | BRSV |
| 3 | Asthma |
| 3 | 2019-nCoV |
| 2 | zoonoses |
| 2 | virology |
| 2 | tuberculosis |
| 2 | transplantation |
| 2 | surveillance |
| 2 | substrate specificity |
| 2 | structure |
| 2 | ssRNA |
| 2 | spike protein |
| 2 | severe acute respiratory syndrome |
| 2 | risk |
| 2 | respiratory viruses |
| 2 | respiratory tract infections |
| 2 | respiratory infections |
| 2 | respiratory infection |
| 2 | respiratory disease |
| 2 | remyelination |
| 2 | reference gene |
| 2 | rabies |
| 2 | quinazolinones |
| 2 | public health |
| 2 | psoriasis |
| 2 | protease |
| 2 | pilgrims |
| 2 | pigs |
| 2 | phylogenetic analysis |
| 2 | phosphonate |
| 2 | pediatric |
| 2 | niclosamide |
| 2 | neuroinvasion |
| 2 | neuraminidase |
| 2 | multiple sclerosis |
| 2 | microbiome |
| 2 | microRNA |
| 2 | melting curve |
| 2 | marrow transplantation |
| 2 | mRNA |
| 2 | livestock |
| 2 | isoxazolidine |
| 2 | interleukins |
| 2 | interferon |
| 2 | influenza virus |
| 2 | inflammation |
| 2 | infectious diseases |
| 2 | infectious bronchitis virus |
| 2 | immunology |
| 2 | immunoinformatics |
| 2 | immunohistochemistry |
| 2 | human diseases |
| 2 | human coronaviruses |
| 2 | feline infectious peritonitis |
| 2 | exacerbation |
| 2 | evolution |
| 2 | essential oil |
| 2 | epitope |
| 2 | environment |
| 2 | emerging infections |
| 2 | effect of therapy |
| 2 | diagnosis |
| 2 | cycloaddition |
| 2 | corticosteroid |
| 2 | contact tracing |
| 2 | chronic obstructive pulmonary disease |
| 2 | central nervous system |
| 2 | cattle |
| 2 | bioavailability |
| 2 | bacteria |
| 2 | azidophosphonates |
| 2 | avian infectious bronchitis virus |
| 2 | apoptosis |
| 2 | antivirals |
| 2 | anti-inflammatory |
| 2 | alphaviruses |
| 2 | aging |
| 2 | acyclonucleotides |
| 2 | acute exacerbation |
| 2 | XDR-TB |
| 2 | World Health Organization |
| 2 | WHO |
| 2 | Virus isolation |
| 2 | UPR |
| 2 | T cells |
| 2 | Surveillance |
| 2 | Severity |
| 2 | Severe acute respiratory syndrome |
| 2 | Seroprevalence |
| 2 | Risk factors |
| 2 | Rhinovirus |
| 2 | Respiratory viral infections |
| 2 | Respiratory syncytial virus |
| 2 | RSV |
| 2 | RNA viruses |
| 2 | Probiotics |
| 2 | Primary care |
| 2 | Prevention |
| 2 | Point-of-care |
| 2 | PCR |
| 2 | Outbreak |
| 2 | Nipah virus |
| 2 | NMR spectroscopy |
| 2 | Mortality |
| 2 | Middle East respiratory syndrome coronavirus (MERS-CoV) |
| 2 | Middle East respiratory syndrome corona virus |
| 2 | Microglia |
| 2 | Macrophage |
| 2 | Lectin |
| 2 | LAMP |
| 2 | Infectious diseases |
| 2 | Infection control |
| 2 | Immunology |
| 2 | Immunology and Microbiology Section |
| 2 | Immunity |
| 2 | Human metapneumovirus |
| 2 | Housekeeping gene |
| 2 | Hajj pilgrims |
| 2 | HCV |
| 2 | Gene expression |
| 2 | Epstein-Barr virus |
| 2 | Epidemic |
| 2 | Endogenous retroviruses |
| 2 | Emerging infectious disease |
| 2 | Emerging diseases |
| 2 | Disease resistance |
| 2 | Diagnostics |
| 2 | Dengue |
| 2 | Dengue virus |
| 2 | DPP4 |
| 2 | Cytokine |
| 2 | Cystic fibrosis |
| 2 | Common cold |
| 2 | Chronic obstructive pulmonary disease |
| 2 | Chikungunya virus |
| 2 | Carrageenan |
| 2 | Cancer |
| 2 | Canada |
| 2 | Camel |
| 2 | Calves |
| 2 | CNS |
| 2 | Brucellosis |
| 2 | Autoimmunity |
| 2 | Acute respiratory infection |
| 2 | Acute respiratory distress syndrome |
| 2 | Acute disseminated encephalomyelitis |
| 2 | Streptococcus pyogenes |
| 2 | Pneumocystis jirovecii |
| 2 | Cryptosporidium |
| 2 | 2019 novel coronavirus |
| 2 | 1,2,3-triazoles |
| 1 | 自身抗体 |
| 1 | 肺肿瘤 |
| 1 | 多肽芯片 |
| 1 | −1 ribosomal frameshifting |
| 1 | فيروس كورونا المسبب لمتلازمة الشرق الأوسط التنفسية |
| 1 | انتقال المرض |
| 1 | الوقاية |
| 1 | العاملين في مجال الرعاية الصحية |
| 1 | β-Catenin |
| 1 | α‐Aminophosphonates |
| 1 | zoonotic disease |
| 1 | zika virus (ZIKV) |
| 1 | xanthine |
| 1 | whole blood |
| 1 | wheezing |
| 1 | virus-host interaction |
| 1 | virus yield reduction assay |
| 1 | virus transmission |
| 1 | virus replication |
| 1 | virus infection |
| 1 | virus growth |
| 1 | virus evolution |
| 1 | virus ecology |
| 1 | virulome |
| 1 | viroporins |
| 1 | viroporin |
| 1 | viremia |
| 1 | viral–bacterial coinfection |
| 1 | viral vectors |
| 1 | viral replication complex |
| 1 | viral persistence |
| 1 | viral pathogenesis |
| 1 | viral laboratory diagnosis. |
| 1 | viral infections |
| 1 | viral infection |
| 1 | viral gene expression |
| 1 | viral envelope glycoproteins |
| 1 | veterinary medicine |
| 1 | vero cells |
| 1 | vegetable |
| 1 | value |
| 1 | vaccine |
| 1 | vaccine design |
| 1 | urothelial cancer |
| 1 | upper respiratory tract infections |
| 1 | upper airway |
| 1 | unit |
| 1 | unfolded protein response |
| 1 | ultraviolet light |
| 1 | ubiquitin like modifier proteins |
| 1 | type-I interferon |
| 1 | tumors |
| 1 | tumor protection |
| 1 | tumor biology |
| 1 | tuberculous lymphadenitis |
| 1 | travel screening |
| 1 | transplant |
| 1 | transmission |
| 1 | transmissible gastroenteritis virus |
| 1 | transmissibility |
| 1 | transmembrane protein folding |
| 1 | transgenic mice |
| 1 | transcription factors |
| 1 | topsentin |
| 1 | toll-like receptor 7 |
| 1 | toll-like receptor 3 |
| 1 | tolerance |
| 1 | titanium dioxide |
| 1 | tissue culture |
| 1 | thymol |
| 1 | thymic involution |
| 1 | thrombin generation |
| 1 | thermodynamics |
| 1 | therapeutics |
| 1 | therapeutic vaccine |
| 1 | therapeutic vaccine against |
| 1 | the E protein |
| 1 | targeted vaccine delivery |
| 1 | targeted enrichment |
| 1 | tannins |
| 1 | systemic lupus erythematosus |
| 1 | synthetic virology |
| 1 | synthetic peptide |
| 1 | synergistic therapeutic efficacy |
| 1 | swine |
| 1 | sustainability |
| 1 | survival curves |
| 1 | surfactant |
| 1 | surface disinfection |
| 1 | super-resolution |
| 1 | suicide attempts |
| 1 | subtype |
| 1 | subtilase |
| 1 | structural genomics |
| 1 | stool bank |
| 1 | stem cell transplantation |
| 1 | statistical analysis |
| 1 | standard |
| 1 | stabilizer |
| 1 | sponge |
| 1 | specialists |
| 1 | spatiotemporal analysis |
| 1 | solvent free conditions |
| 1 | solubilizer |
| 1 | small membrane protein |
| 1 | small hydrophobic protein |
| 1 | site-directed bone formation |
| 1 | single-stranded RNA |
| 1 | single nucleotide substitution |
| 1 | silicone pneumonitis |
| 1 | silicone embolization syndrome |
| 1 | signaling |
| 1 | severe combined immunodeficient mice |
| 1 | severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) |
| 1 | severe acute respiratory infections |
| 1 | severe acute respiratory infection (SARI) |
| 1 | serum |
| 1 | serotherapy |
| 1 | serology |
| 1 | serology, calves |
| 1 | sequencing |
| 1 | sequence |
| 1 | sepsis |
| 1 | secretogranin II |
| 1 | secondary metabolites |
| 1 | seasonal influenza vaccination |
| 1 | screening |
| 1 | saikosaponins |
| 1 | safety |
| 1 | sWAT, subcutaneous white adipose tissue |
| 1 | sARS-CoV-2 |
| 1 | rmDPP4, recombinant mouse dipeptidyl peptidase 4 |
| 1 | risk perception |
| 1 | risk communication |
| 1 | rice |
| 1 | riboswitch |
| 1 | rhinoviruses |
| 1 | rheumatoid arthritis |
| 1 | rhabdoviruses |
| 1 | rhabdovirus |
| 1 | rhDPP4, recombinant human dipeptidyl peptidase 4 |
| 1 | retrovirus |
| 1 | retinoic acid response element (RARE) |
| 1 | response |
| 1 | respiratory virus infection |
| 1 | respiratory viral infections |
| 1 | respiratory viral infection |
| 1 | respiratory tract infection |
| 1 | respiratory therapy |
| 1 | respiratory infections, France, Saudi Arabia, viruses |
| 1 | resource |
| 1 | resistome |
| 1 | resistance |
| 1 | research |
| 1 | reproduction |
| 1 | replicase inhibitors |
| 1 | relative adrenal insufficiency |
| 1 | regulated cell death |
| 1 | reference genes |
| 1 | redox signaling |
| 1 | recombination |
| 1 | recombinant particles |
| 1 | real-time qPCR |
| 1 | quantitative trait locus |
| 1 | qRT-PCR |
| 1 | pyrazolylnucleosides |
| 1 | pyothorax |
| 1 | pyometra |
| 1 | puromycin |
| 1 | pulmonary tuberculosis |
| 1 | public health surveillance |
| 1 | public health informatics |
| 1 | psychotropic activity |
| 1 | psorales |
| 1 | pseudotyped virus |
| 1 | pseudoknot |
| 1 | protein-protein interactions |
| 1 | protein-homeostasis-system |
| 1 | protein structure prediction |
| 1 | protein kinases |
| 1 | protein kinase RNA activated |
| 1 | protective |
| 1 | protection against lethal virus challenges |
| 1 | prostaglandins |
| 1 | promiscuous binding peptide |
| 1 | probiotics |
| 1 | probable drug targets |
| 1 | prion disease |
| 1 | primary immunodeficiencies |
| 1 | primary health care |
| 1 | primary biliary cirrhosis |
| 1 | prevention |
| 1 | premature neonates |
| 1 | preclinical study |
| 1 | preclinical model |
| 1 | postexertional malaise |
| 1 | positive-sense RNA viruses |
| 1 | porcine |
| 1 | porcine respiratory coronavirus |
| 1 | porcine reproductive and respiratory syndrome |
| 1 | polyvalency |
| 1 | polyphenols |
| 1 | polyomaviruses |
| 1 | polymer model |
| 1 | platelets |
| 1 | plasmacytoid dendritic cell |
| 1 | plant–pathogen interaction |
| 1 | plague |
| 1 | phytosulfokine |
| 1 | phytomedicine |
| 1 | phylogeny |
| 1 | photodynamic therapy |
| 1 | photocatalytic inactivation |
| 1 | photocatalysis |
| 1 | photo inactivation |
| 1 | pharmacological efficacy |
| 1 | pharmacokinetics/pharmacodynamics |
| 1 | pharmaceuticals |
| 1 | phage display |
| 1 | persistent infection |
| 1 | peripheral neuropathy |
| 1 | peptide hormone |
| 1 | pecking problem |
| 1 | pattern recognition receptor |
| 1 | patient |
| 1 | pathogenesis |
| 1 | pathogen genomics |
| 1 | patents |
| 1 | parasites |
| 1 | paraprobiotics |
| 1 | parameter estimation |
| 1 | parainfluenza |
| 1 | papain like enzyme |
| 1 | pandemic (H1N1) 2009 |
| 1 | paediatrics |
| 1 | pGlo |
| 1 | pAkt, phosphorylated Akt serine–threonine protein kinase |
| 1 | p-cymene |
| 1 | osteonecrosis of the femoral head |
| 1 | oseltamivir |
| 1 | open reading frames |
| 1 | one-pot reverse transcription (RT) |
| 1 | on-site detection |
| 1 | oligodendrocytes |
| 1 | oligodendrocyte precursors |
| 1 | ocelot |
| 1 | nucleoside reverse transcriptase inhibitors |
| 1 | nucleocapsid |
| 1 | nucleocapsid (N) protein |
| 1 | nucleic acid techniques |
| 1 | nucleic acid detection |
| 1 | nucleic acid amplification test |
| 1 | nuclear factor-κB |
| 1 | nsp2 |
| 1 | nsP2 |
| 1 | novel |
| 1 | novel coronaviruses |
| 1 | normalization |
| 1 | nordihydroguaiaretic acid |
| 1 | nonstructural proteins |
| 1 | nonstructural protein 2 |
| 1 | nonmyeloablative |
| 1 | nonmyeloablative conditioning |
| 1 | nivolumab |
| 1 | next-generation sequencing |
| 1 | next-generation sequencing (NGS) |
| 1 | newcastle disease virus |
| 1 | new applications |
| 1 | neutralizing antibody |
| 1 | neutralizing antibodies |
| 1 | neutral red uptake assay |
| 1 | neurotropism |
| 1 | neurotransmitters |
| 1 | neuroregulation |
| 1 | neuropropagation |
| 1 | neuropathogenesis |
| 1 | neurological complications |
